Use the Back button in your browser to see the other results of your search or to select another record.
| VenaFlow plus Lovenox versus VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty |
| Westrich GH, Bottner F, Windsor RE, Laskin RS, Haas SB, Sculco TP |
| The Journal of Arthroplasty 2006 Sep;21(6 Suppl 1):139-143 |
| clinical trial |
| 4/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: No; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
Copyright release for this abstract has not been granted.
|